Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City

American Journal of Public Health

Volumn 97, Issue 1, 2007, Pages 117-124

  Fuller, Crystal M ^a,b   Galea, Sandro ^a   Caceres, Wendy ^a   Blaney, Shannon ^a   Sisco, Sarah ^a   Vlahov, David ^a  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COMMUNITY; COUNSELING; DEMOGRAPHY; EXPANDED SYRINGE ACCESS DEMONSTRATION PROGRAM; FEMALE; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION DISSEMINATION; INTERVENTION STUDY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEGRO; PHARMACIST; PHARMACY; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COMMUNITY HEALTH PLANNING; COUNSELING; FEMALE; HEALTH EDUCATION; HEALTH SERVICES RESEARCH; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; NEW YORK CITY; PHARMACIES; RISK REDUCTION BEHAVIOR; RISK-TAKING; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; URBAN HEALTH SERVICES;

EID: 33846090745     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.069591     Document Type: Article

References (36)

1. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy of Medicine; 1995.
2. Rich JD, Strong L, Towe CW, McKenzie M. Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr. 1999;21(5):396-400.
3. Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol 1997;18(1):61-83.
4. Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995;85(11):1531-1537.
5. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77(3):369-382.
6. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154(12):S70-S77.
7. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;48(9033):987-991
8. Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S45-S51.
9. Rockwell R, Des Jarlais DC, Friedman SR, Perils TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999;11(4):437-442.
10. Lazzarini Z, Schoenbaum EE, O'Neill CH. In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S141-S143.
11. Vlahov D, Fuller C, Finkelstein R, et al. New York State Expanded Syringe Access Demonstration Program: Evaluation Report to the Governor and the New York State Legislation. New York, NY: New York Academy of Medicine; 2003.
12. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002;42(6, Suppl 2):S77-S82.
13. Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. J Am Pharm Assoc (Wash). 2002;42(6):S73-S76.
14. Deren S, Fuller CM, Poujet ER, et al. Impact of expanding syringe access in New York on sources of syringes for IDUs in Harlem and the Bronx. Int J Drug Policy. 2003;14(5-6):373-379.
15. Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005;39(4):471-477.
16. Galea S, Factor SH, Bonner S, et al. Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Rep. 2001;116:530-539.
17. Fuller CM, Borrell LN, Latkin CA, et al. The effect of race, neighborhood, and social network on adolescent initiation of injection drug use. Am J Public Health. 2005;95(4):689-695.
18. Sorensen G, Emmons K, Hunt MK, et al. Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations. Prev Med. 2003;37(3):188-197.
19. Fortmann SP, Varady AN. Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project. Am J Epidemiol. 2000;152(4):316-323.
20. Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173-202.
21. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14(Suppl 1):S11-21.
22. Goldmon MV, Roberson JT Jr. Churches, academic institutions, and public health: partnerships to eliminate health disparities. N C Med J. 2004;65(6):368-372.
23. Adams A, Miller-Korth N, Brown D. Learning to work together: developing academic and community research partnerships. WMJ. 2004;103:15-19.
24. Lasker RD, Weiss ES. Broadening participation in community problem solving: a multidisciplinary model to support collaborative practice and research. J Urban Health. 2003;80(1):14-47.
25. Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis. 2005;191(Suppl 1):S7-24.
26. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322-1327.
27. Kegeles SM, Hays RB, Coates TJ. The Mpowerment Project: a community-level HIV prevention intervention for young gay men. Am J Public Health. 1996;86(8 Pt 1):1129-1136.
28. Waterman SH, Hill LL, Robyn B, et al. A model immunization demonstration for preschoolers in an inner-city barrio, San Diego, California, 1992-1994. Am J Prev Med. 1996;12(4 Suppl):8-13.
29. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998;113 (Suppl 1):19-30.
30. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993;6(9):1049-1056.
31. Vlahov D. The role of epidemiology in needle exchange programs. Am J Public Health. 2000;90(9):1390-1392.
32. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales-Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):73-81.
33. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):82-89.
34. Diaz T, Chu SY, Weinstein B, Mokotoff E, Jones TS. Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S76-81.
35. Fuller CM, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease. 2004;14:589-596.
36. Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc (Wash). 2002;42(6 Suppl 2):S62-S67.